Patent details
EP2066353 Title: COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY
Basic Information
- Publication number:
- EP2066353
- PCT Application Number:
- PCT/GB/2007/003667
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP078044047
- PCT Publication Number:
- WO/2008/037996
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION OF ZD6474 AND BEVACIZUMAB FOR CANCER THERAPY
- French Title of Invention:
- ASSOCIATION DE ZD6474 ET DE BEVACIZUMAB POUR TRAITER LE CANCER
- German Title of Invention:
- KOMBINATION VON ZD6474 UND BEVACIZUMAB FÜR DIE KREBSTHERAPIE
- SPC Number:
Dates
- Filing date:
- 27/09/2007
- Grant date:
- 02/01/2013
- EP Publication Date:
- 02/01/2013
- PCT Publication Date:
- 03/04/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/06/2009
- EP B1 Publication Date:
- 02/01/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/09/2013
- Expiration date:
- 27/09/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/09/2007
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
- Name:
- RYAN Anderson, Joseph
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 827483 P
- Priority Date:
- 29/09/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/22;
| Filing date | Document type | Number of pages |
|---|